EUVIMEDEUVIMED entdecken
Crossref

Fatal adverse reactions to injectable ceftriaxone sodium in Syrian Arab Republic

Abeer Srour, Basima Arous, Mohammad Amer Al-Mardini

Eastern Mediterranean Health Journal · 08.06.2026 · 32 (5) · 320-324

DOI: 10.26719/2026.32.5.320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eastern Mediterranean Health Journal, online erschienen am 08.06.2026. Verfasst von Abeer Srour und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry and Quality Control, Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Ceftriaxone. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reports of fatal adverse reactions to ceftriaxone sodium have raised serious safety concerns in Syrian Arab Republic, yet evidence describing fatal outcomes remains limited.

Aim

To describe and characterise fatal adverse reactions associated with ceftriaxone sodium administration in Syrian Arab Republic.

Methods

We conducted a retrospective analysis of 14 fatal cases of ceftriaxone-associated adverse reactions reported to the national pharmacovigilance system in Syrian Arab Republic from 2018 to 2023.

Results

Fourteen ceftriaxone sodium-associated fatal ADR cases were identified, including one maternal-foetal case, accounting for 15 deaths. Most fatalities resulted from immediate anaphylactic reactions following intravenous or intramuscular administration. Fatal outcomes included maternal-foetal death, Stevens-Johnson syndrome with multiorgan failure and anaphylaxis occurring during an intradermal allergy test.

Conclusion

Fatal adverse reactions to ceftriaxone were predominantly rapid and unpredictable, underscoring the need for careful allergy assessment, close patient monitoring and adherence to safe administration practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCeftriaxoneHumansRetrospective StudiesSyriaFemaleMaleAnaphylaxisAdultPharmacovigilanceMiddle Aged

Stichwörter der Autor:innen

Syriaanaphylaxisceftriaxonefatal adverse reactionpharmacovigilance

Substanzen

Anti-Bacterial AgentsCeftriaxone

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry and Quality Control, Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic.

Zitieren

APA

Srour, A., Arous, B., & Al-Mardini, M. A. (2026). Fatal adverse reactions to injectable ceftriaxone sodium in Syrian Arab Republic. Eastern Mediterranean Health Journal, 32(5), 320-324. https://doi.org/10.26719/2026.32.5.320

Vancouver

Srour A, Arous B, Al-Mardini MA. Fatal adverse reactions to injectable ceftriaxone sodium in Syrian Arab Republic. Eastern Mediterranean Health Journal. 2026;32(5):320-324. doi:10.26719/2026.32.5.320

BibTeX
@article{Srour2026,
  author = {Srour, Abeer and Arous, Basima and Al-Mardini, Mohammad Amer},
  title = {Fatal adverse reactions to injectable ceftriaxone sodium in Syrian Arab Republic},
  journal = {Eastern Mediterranean Health Journal},
  year = {2026},
  volume = {32},
  number = {5},
  pages = {320--324},
  doi = {10.26719/2026.32.5.320}
}
Kostenlos starten →